tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
PremiumThe FlyPsychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
26d ago
Clearmind Medicine enrolls first patient in Phase I/IIa trial for CMND-100
Premium
The Fly
Clearmind Medicine enrolls first patient in Phase I/IIa trial for CMND-100
28d ago
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
Premium
The Fly
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
28d ago
Psychedelic: Clearmind engages government, political affairs consulting firm
PremiumThe FlyPsychedelic: Clearmind engages government, political affairs consulting firm
1M ago
Clearmind Medicine engages lobbying firm to advance psychedelic therapeutics
Premium
The Fly
Clearmind Medicine engages lobbying firm to advance psychedelic therapeutics
1M ago
Psychedelic: atai, Beckly Psytech to combine in all-share transaction
Premium
The Fly
Psychedelic: atai, Beckly Psytech to combine in all-share transaction
2M ago
Clearmind Medicine announces publication of European patent application
PremiumThe FlyClearmind Medicine announces publication of European patent application
2M ago
SciSparc announces collaboration with Clearmind Medicine
Premium
The Fly
SciSparc announces collaboration with Clearmind Medicine
3M ago
Clearmind files international patent application for eating disorder treatment
Premium
The Fly
Clearmind files international patent application for eating disorder treatment
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100